GPT and metabolic dysfunction-associated steatotic liver disease: A meta-analysis demonstrated that SGLT2i improves not only glucose and lipid metabolisms but also serum hepatic enzyme levels including alanine aminotransferase (ALT) in patients with MASLD [7].